Gibb D, et al. Impact of raltegravir intensification of first-line art on IRIS in the REALITY trial. CROI 2018. Abstract 23.
Meer behandelopties, flexibeler inzetbaar en uniformer gemonitord
mrt 2024 | Multipele Sclerose, Stamceltransplantatie, Vaccinatie